(Q35464735)

English

THE LSD CONTROVERSY.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

THE LSD CONTROVERSY. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

lysergic acid diethylamide

1 reference

based on heuristic

inferred from title

author name string

LEVINE J

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

LUDWIG AM

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

1 October 1964

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Comprehensive Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

314-321

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

The use of L.S.D. 25 (D-lysergic acid diethylamide) in the treatment of the sexual perversions.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

The identification and treatment of an early deprivation syndrome in alcoholics by means of LSD-25

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Some aspects of an office practice utilizing LSD 25

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Analytic work with LSD 25

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Complications associated with lysergic acid diethylamide (LSD-25)

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Prolonged Adverse Reactions to Lysergic Acid Diethylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Use of lysergic acid diethylamide in a psychotherapeutic setting

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Psychotherapy with lysergic acid diethylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Clinical and laboratory observations on ISD-25

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

An experimental approach to facilitation of psychotherapy by psychotomimetic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

A controlled trial of abreaction with lysergic acid diethylamide (LSD-25)

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Psychological aspects of the LSD treatment of the neuroses

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

The therapeutic value of lysergic acid diethylamide in mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Further studies in the therapeutic value of lysergic acid diethylamide in mental illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

The resolution and subsequent remobilization of resistance by LSD in psychotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

The placebo effect in the history of medical treatment: implications for psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Permissive group therapy with lysergic acid diethylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Mescaline, LSD, psilocybin, and personality change

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

Lysergic acid diethylamide: side effects and complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2864%2980010-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0010-440X(64)80010-9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35464735&oldid=1615492730"